Health, innovation and development, by Carlos Gadelha and Célio Hiratuka
Health Economic-Industrial Complex serves as the central axis of this profound analysis regarding how technological innovation can act as the primary engine for reducing social inequalities and guaranteeing national sovereignty. In this academic and analytical record from the Unicamp Institute of Economics, experts Célio Hiratuka and Philippe Kamya deconstruct the dynamics of the global pharmaceutical industry through the lens of financialization. Hiratuka explores how large corporations capture value through intangible assets and intellectual monopolies, creating entry barriers for developing nations. The Chinese case is presented as a robust example of overcoming these hurdles, where aggressive state coordination combined tax incentives, public procurement, and high-level capacity building to transform the country into a biotechnological powerhouse. Philippe Kamya, representing Carlos Gadelha, brings the Brazilian perspective, focusing on the role of the Unified Health System (SUS) as a driver for innovation. He details the structure of the Health Economic-Industrial Complex in Brazil, explaining how technological dependence on Active Pharmaceutical Ingredients (APIs) makes the public system vulnerable. The analysis discusses Partnerships for Product Development (PDPs) and how the State's purchasing power can be utilized to internalize critical technologies, as seen with COVID-19 vaccines. This content is essential for public managers, economists, health researchers, and students seeking to understand why health is not merely an expense, but a strategic economic sector that generates high-skilled jobs and national security. The final reflection points out that virtuous development requires that social rights, such as universal access to health, be viewed as part of the solution for sustainable economic growth. 00:00:00 – Introduction: Health, Innovation, and Global Inequalities 00:04:37 – The Concept of Financialization in the Pharmaceutical Industry 00:10:05 – Structural Barriers: Intellectual Monopolies and Intangible Assets 00:16:31 – Big Pharma Strategies: R&D vs. Dividends 00:24:11 – The Case of China: Health System Reform and Universalization 00:33:24 – Chinese Innovation Policies: State Coordination and Incentives 00:49:04 – Health Development in Brazil: The Role of the SUS 01:09:46 – Structuring the Health Economic-Industrial Complex (HEIC) 01:23:02 – Brazilian Vulnerabilities: API Dependence and Trade Deficit 01:45:33 – Partnerships for Product Development (PDPs) and the Future Between June 24th and July 5th, Unicamp, in partnership with the Institute of Economics (IE) and the Institute of Geosciences (IGE), held the “São Paulo Advanced School on Technology & Innovation Strategies and Policies for Economic Development” (SPAS). The program also integrates the 5th Unicamp International School on Development Challenges, the IV International School of the BRICS Network University, and the 3rd BRICS Postgraduate Forum. Activities include plenary lectures, intensive courses, roundtables, and extracurricular activities. #HealthEconomicIndustrialComplex #HealthInnovation #PublicHealth #EconomicDevelopment #NationalSovereignty
